首页>
美国卫生研究院文献>other
>Dopamine Reduction in the Substantia Nigra of Parkinsons Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging
【2h】
Dopamine Reduction in the Substantia Nigra of Parkinsons Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging
ObjectivesMetabolic changes in the substantia nigra of patients with Parkinson's disease were previously investigated in different molecular-pathological examinations. The aim of our study was the in vivo measurement of these alterations using three-dimensional magnetic resonance spectroscopic imaging.
展开▼